QSOX2: A Promising Drug Target / Biomarker (G169714)

Target Name: QSOX2

NCBI ID: G169714

QSOX2

QSOX2: A Promising Drug Target / Biomarker

QSOX2 is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues throughout the body. Despite its importance, QSOX2 is not well understood, and its functions and potential as a drug target or biomarker are still being explored.

The QSOX2 gene

The QSOX2 gene is located on chromosome 16 at position 23.3 kb. It encodes a 21-kDa protein that is composed of 214 amino acid residues. The protein has a characteristic topology, with a N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal T-loop domain. The QSOX2 protein is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines, and is involved in the development and maintenance of tissues throughout the body.

QSOX2 functions

QSOX2 is involved in the regulation of cell growth and differentiation. It plays a key role in the development and maintenance of tissues, such as the lungs, heart, and kidneys. It is also involved in the regulation of cell survival and apoptosis.

In addition to its functions in cell growth and differentiation, QSOX2 is also involved in the regulation of cell survival and apoptosis. It has been shown to play a role in the regulation of cell apoptosis, and has been shown to promote the apoptosis of certain cancer cells.

Potential as a drug target

QSOX2 is a protein that is involved in various functions in the body, and as such, it has the potential to be targeted as a drug. One of the potential mechanisms by which QSOX2 could be targeted as a drug is through its role in cell growth and differentiation.

By inhibiting the functions of QSOX2, it may be possible to prevent or reverse the development and growth of cancer cells. This could be done through a variety of mechanisms, such as inhibiting the ability of QSOX2 to regulate cell growth and differentiation, or by disrupting the processes that QSOX2 is involved in.

Another potential mechanism by which QSOX2 could be targeted as a drug is through its role in cell apoptosis.

By inhibiting the functions of QSOX2, it may be possible to prevent or reverse the process of apoptosis, which is a natural and important process for the regulation of cell survival. This could be done through a variety of mechanisms, such as inhibiting the ability of QSOX2 to promote the apoptosis of certain cancer cells.

Conclusion

QSOX2 is a protein that is expressed in various tissues of the body, and is involved in the development and maintenance of tissues throughout the body. Despite its importance, QSOX2 is not well understood, and its functions and potential as a drug target or biomarker are still being explored. Further research is needed to fully understand the role of QSOX2 in the regulation of cell growth and differentiation, and to determine its potential as a drug.

Protein Name: Quiescin Sulfhydryl Oxidase 2

Functions: Catalyzes the oxidation of sulfhydryl groups in peptide and protein thiols to disulfides with the reduction of oxygen to hydrogen peroxide. May contribute to disulfide bond formation in a variety of secreted proteins. Also seems to play a role in regulating the sensitization of neuroblastoma cells for interferon-gamma-induced apoptosis

The "QSOX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about QSOX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets